Entering text into the input field will update the search result below

Atea Pharmaceuticals GAAP EPS of -$0.34 beats by $0.15

Aug. 08, 2023 5:49 PM ETAtea Pharmaceuticals, Inc. (AVIR)By: Urvi Shah, SA News Editor
  • Atea Pharmaceuticals press release (NASDAQ:AVIR): Q2 GAAP EPS of -$0.34 beats by $0.15.
  • Cash, Cash Equivalents and Marketable Securities: $608.1 million at June 30, 2023 compared to $646.7 million at December 31, 2022.


Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About AVIR

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Atea Pharmaceuticals, Inc.
Xeris Biopharma Holdings, Inc.
Nuvation Bio Inc.
Terns Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.